Clenbuterol treatment increases femoral artery blood flow velocity
As we were unable to ascribe the effects of clenbuterol treatment to an enhanced skeletal muscle GLUT4 translocation or mTORC2 activation, we next investigated potential physiological mechanisms underlying the enhanced insulin-stimulated peripheral glucose uptake and first focussed on haemodynamic outcome parameters. Thus, two weeks of clenbuterol administration tended to significantly increase systolic blood pressure by ~3 mmHg (